Xie, Xian <br/><br/>
Nicotinamide ribose ameliorates cognitive impairment of aged and Alzheimer's disease model mice.  [electronic resource] 

 -  Metabolic brain disease  02 2019 
 - 353-366 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1573-7365 
<br/><br/><label>Standard No.: </label>10.1007/s11011-018-0346-8  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Alzheimer Disease--drug therapy<br/>Amyloid beta-Peptides--metabolism<br/>Amyloid beta-Protein Precursor--metabolism<br/>Animals<br/>Astrocytes--drug effects<br/>Brain--drug effects<br/>Cognition--drug effects<br/>Cognitive Dysfunction--drug therapy<br/>Disease Models, Animal<br/>Memory--drug effects<br/>Mice<br/>Microglia--drug effects<br/>Motor Activity--drug effects<br/>Niacinamide--analogs & derivatives<br/>Nicotinamide Phosphoribosyltransferase--blood<br/>Pyridinium Compounds